Viewpoint: Breaking through limitations

Article

Alexander Kabiri, OD, who practices at Malik Eye Care in Queens, NY, is a third-degree black belt in Zujitsu, an eclectic style of martial arts rooted in multiple, traditional disciplines.

Alexander Kabiri, OD, is looking for ways to "lengthen his line."

His journey started 14 years ago, when he spotted an old friend working at a restaurant. "We used to roughhouse with each other," Dr. Kabiri said. "So I snuck up behind him and snatched him up in a chokehold, just like we did in high school. The next thing I knew, I went flying over his shoulder. He dumped me right on to a table, which collapsed. Thankfully, he kept his job and we had a good laugh about it."

Dr. Kabiri was so impressed by his friend's ability that he began exploring various martial arts disciplines. He chose to study Zujitsu, mainly because of its unique philosophy and versatility as a self-defense system.

He believes some forms of martial arts are watered down, providing students with simply a product. But studying Zujitsu, Dr. Kabiri said, is a developmental process. Students become aware of their physical, mental, and emotional limitations-which he calls "reference points"-and learn how to surpass them, moving on to more and more difficult challenges throughout their life.

Dr. Kabiri noted that one of the biggest differences between Zujitsu and many traditional martial arts is that the latter train students to use very specific techniques in wide open versus confined spaces. For example, students may learn how to fight an assailant wielding a knife or weapon or defend themselves against a group street attack. But the techniques aren't always realistic or adaptable to everyday life, especially for students living in urban environments.

Flexibility is key

"You could be in a small space like an elevator, subway, stairwell, or getting out of your car," Dr. Kabiri explained. "That's a different kind of fight and you have to train for it. We're trained in all types of situations, pretty much fighting every imaginable scenario."

For example, he has trained blindfolded, standing, seated, lying on the ground, in the water, and also with an armed person and unarmed group of opponents. Some of his students include police officers as well as a security guard and nurse who work in psychiatric facilities.

Dr. Kabiri recently uploaded three videos on YouTube that show him executing Zujitsu. To watch the videos, go to http://www.youtube.com/ and search for Alex Kabiri.

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.